Beside being one of the best characterized anti-apoptotic factors [14], Survivin is the object of intense investigation due to the fact that in adults it is selectively expressed virtually only by cancers of different origin; moreover, its expression in the primary tumor has been associated with worse prognosis and resistance to conventional chemotherapeutics [15]. Here, BIRC5 is linked to cancer.